Combined oral therapy with sildenafil and doxazosin for the treament of non-organic erectile dysfunction refractory to sildenafil monotherapy-Reference-Cited by-同舟云学术

Combined oral therapy with sildenafil and doxazosin for the treament of non-organic erectile dysfunction refractory to sildenafil monotherapy

Published:2002-02 Issue:1 Volume:14 Page:50-53
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

De Rose A F,Giglio M,Traverso P,Lantieri P,Carmignani G

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/3900815.pdf

Reference24 articles.

1. NIH Consensus Development Panel on Impotence. . NIH Consensus Conference. JAMA 1993 270: 83–90.

2. Krane RJ. . Changes in ED therapy in the Viagra era. World J Urol 2001 19: 23–24.

3. Padma-Nathan H, Steers WD, Wicker PA. . Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract 1998 52: 375–379.

4. Goldstein I et al . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Engl J Med 1998 338: 1397–1404.

5. Diederichs W et al . The sympathetic role as antagonist of erection. Urol Res 1991 19: 123–126.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in psychogenic erectile dysfunction research: a bibliometric and visualized study;Journal of Men's Health;2024

2. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors;Uro;2021-07-05

3. Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia;Minerva Urologica e Nefrologica;2020-02

4. Unreliability of the Duplex Scan in Diagnosing Corporeal Venous Occlusive Disease in Young Healthy Men With Erectile Deficiency;Urology;2018-03

5. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails;Drugs & Aging;2018-02-20